Buscar resultados de ensayos clínicos
Anemia, Sickle Cell - 31 Studies Found
| Estado | Estudiar |
| Terminated |
Nombre del estudio: Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository) Condición: Anemia, Sickle Cell Fecha: 2007-09-10 |
| Completed |
Nombre del estudio: Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease Condición: Sickle Cell Disease Fecha: 2010-03-25 |
| Completed |
Nombre del estudio: PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease Condición: Sickle Cell Disease Fecha: 2006-06-21 Intervenciones: Drug: L-citrulline tablets, 1000 mg |
| Completed |
Nombre del estudio: Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease Condición: Sickle Cell Disease Fecha: 2009-05-27 Intervenciones: Drug: GMI-1070 Intravenous GMI-1070 given as two doses over the course of one day |
| Completed |
Nombre del estudio: Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) Condición: Sickle Cell Disease Fecha: 2015-05-27 Intervenciones: Other: SCD Group No Intervention. Use of discard blood/tissue |
| Completed |
Nombre del estudio: Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients Condición: Pulmonary Hypertension Fecha: 2009-12-01 |
| Completed |
Nombre del estudio: Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) Condición: Pain Fecha: 2016-09-01 Intervenciones: Device: SMART app wearable Patients will be given a wearable such as a Microsoft Band accelerometer to t |
| Completed |
Nombre del estudio: Fresh Versus Old Red Blood Cells for Transfusion Condición:
Fecha: 2011-03-18 Intervenciones:
|
| Completed |
Nombre del estudio: Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A Condición: Infections, Streptococcal Fecha: 2010-08-03 Intervenciones:
|
| Completed |
Nombre del estudio: Siplizumab for Sickle Cell Disease Transplant Condición: Anemia, Sickle Cell Fecha: 2025-11-04 Intervenciones: Premedication with diphenhydramine 50 mg PO is to be given 1 hour prior to siplizumab infusion.Premedication with hydrocortisone succinate 100 m |